B2B Central

Markets

30 Nov 2021

BlackRock's Weekly Market Commentary: Staying invested amid new virus strain

By Staff Writer

Omicron could trigger growth downgrades, worsen risk sentiment and hit services sectors, especially in the near term.
30 Nov 2021

Why the rand is more likely to strengthen from its current level

By Staff Writer

All of the bad news is currently priced into the value of the rand.
29 Nov 2021

The uncertainty over whether vaccines will be effective against Omicron won’t help uptake, says Nedbank CIB

By Staff Writer

The market will be keeping a very close eye on real-world data in Gauteng.
16 Nov 2021

BlackRock’s Weekly Market Commentary: Inflation at heart of our Outlook Forum

By Staff Writer

BlackRock sees price pressures to persist in 2022, mostly driven by the unusual restart dynamics. Eventually, they see a higher inflation regime than pre-Covid.
08 Nov 2021

Novare bets on local bonds as it awaits better equity opportunities

By Staff Writer

Novare has taken refuge in South African bonds over equities as the asset manager prepares for share prices to drop before boosting its stock allocation.